01 Sep 2011

Haematology oncology education day for allied health

Share this page Email this page to a friend Share this page via Twitter Share this page via Facebook Share this page via LinkedIn

This free event was sponsored by the Cancer Institute NSW and the NSW Oncology Group (NSWOG) Haematology Oncology. The day was designed for allied health professionals working with people who have haematological cancer. Experts explored issues relating to the management of specific haematological cancers from the medical, allied health and patient perspectives. There was also an opportunity to view displays from various specialty groups.

webstreamLive streaming

The event was was streamed live via synchronised video and slideshow webcast.

 

Get Microsoft SilverlightThese videos will open in a new window, and require the free Microsoft Silverlight plugin to be installed.

Please send us your feeback

We hope that you benefit from watching the webcast recordings. We invite you to provide feedback on how useful and effective this technology is by completing this short survey.

Welcome and Lymphoma - a disease overview

Dr Judith Trotman

Dr Judith Trotman

Haematologist, Concord Hospital

Dr Judith Trotman is the Deputy Chair of NSWOG Haematology Oncology. In this session,  Dr Trotman officially opens the Haematology Oncology Allied Health Education Day and presents an overview of the characteristics of lymphoma, diagnostic tools and management strategies.

Lymphoma - the role of imaging

Dr Ivan Ho Shon

Dr Ivan Ho Shon

Senior Staff Specialist, Dept Nuclear Medicine and PET Liverpool Hospital 

Dr Ivan Ho Shon discusses the role of medical imaging in relation to lymphoma. He looks at utility in the diagnosis, staging and monitoring of response to treatment of lymphoma with particular emphasis on the role of PET/CT.

AIDS related lymphoma - a rare subtype

Dr Sam Milliken

Dr Sam Milliken

Haematologist, St Vincents Hospital

HIV/AIDS related lymphoma presents special challenges in treatment and management. Dr Milliken talks about HIV and malignancy with particular reference to lymphoma, including some of the new rare types seen in this patient population, and its treatment.

Clinical Trials

ian kerridge

Associate Professor Ian Kerridge

Haematologist, Royal North Shore Hospital

In this session A/Prof Kerridge presents on clinical research. He invites audience participation and discussion on reasons for doing clinical research and clinical trials, with an emphasis on haematology. He also discusses participation in trials - including barriers and facilitators, as well as ethics, governance and problem areas.

Lymphoma - the role of radiotherapy

michael barton

Professor Michael Barton

Professor of Radiation Oncology, UNSW

Radiation therapy is an important tool in the treatment of most cancers including lymphoma. Professor Barton describes how radiation therapy works, why lymphoma is treated with radiation, strategies employed with different lymphoma types, its role in relation to chemotherapy, and his special interest area of CNS lymphoma.

Palliative care in haematology

sally greenaway

Dr Sally Greenaway 

Staff Specialist Palliative Care, Clinical Haematology, Westmead Hospital

Dr Sally Greenaway offers the unique viewpoint of a specialist in both Palliative Care and Haematology as she introduces the audience to palliative care, and what happens when disease becomes incurable and the goals of care change. She illustrates concepts with a series of clinical vignettes.

Navigating the lymphoma experience

shiraz abdulla

Shiraz Abdulla

Haematology Cancer Care Co-ordinator, Concord Hospital

Dealing with a complex disease in a complicated health system can be like navigating a maze. Shiraz Abdullah discusses the goals of cancer care coordination, what coordinators do and how it lessens the impact of cancer on lymphoma patients.

Living with lymphoma

bronwyn evans

Bronwyn Evans

This is Bronwyn Evans' story of her two and a half year journey with small bowel MALT lymphoma. It follows her progress through initial presentation with a small bowel obstruction through treatment, recurrence and follow-up.

Event details and registration

Date/Time 1 Sep 2011

Please note:
Events publicised on this website align to the goals and objectives of the NSW Cancer Plan 2011-2015, are evidence-based, not-for profit and are conducted by:

  • Professional colleges
  • Cancer councils
  • State-based, national and international cancer control organisations and agencies.
  • Cancer or health services
  • Government organisations
  • Academic institutions.

The Cancer Institute NSW will consider events that meet this criteria on a case-by-case basis, and will not support activities or groups that do not comply with strict evidence-based principles.

Top of page